Safety Study of Prucalopride in Healthy Volunteers
NCT00793429 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2008-11-21
Summary
In this study healthy volunteers received increasing doses of prucalopride to study the tolerability and cardiac safety of prucalopride. The study hypothesis was that prucalopride at doses up to 10 mg has no clinically relevant effect on the cardiovascular safety in healthy volunteers.
Conditions
- Healthy
Interventions
- DRUG
-
Prucalopride
- OTHER
-
Placebo
Sponsors & Collaborators
-
Movetis
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
More Related Trials
-
Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation
NCT00631813 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP)
NCT00793247 ·Status: COMPLETED ·Phase: PHASE2
-
Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation
NCT00596596 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Prucalopride for the Treatment of Patients With Chronic Constipation
NCT00485940 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic Constipation
NCT01070615 ·Status: COMPLETED ·Phase: PHASE3
-
Prucalopride in Patients With Chronic Idiopathic Constipation
NCT00575614 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Prucalopride for the Treatment of Elderly Patients With Chronic Constipation
NCT00487422 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Prucalopride to Treat Chronic Constipation
NCT00488137 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of the Effect of Dose-Titration of Prucalopride for The Treatment of Chronic Constipation
NCT00577018 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Prucalopride for the Re-Treatment of Chronic Constipation
NCT00598338 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Prucalopride for the Treatment of Chronic Constipation
NCT00483886 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon Activity
NCT01707667 ·Status: COMPLETED ·Phase: PHASE4
-
Prucalopride for Postoperative Ileus in Patients Undergoing Gastrointestinal Surgery
NCT02004652 ·Status: COMPLETED ·Phase: PHASE2
-
Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG Parameters
NCT00903747 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of PEG, Bisacodyl and Prucalopride on Colonic Motility in Healthy Subjects
NCT03279341 ·Status: COMPLETED ·Phase: PHASE4
-
Prucalopride Subjects With Renal Impairment
NCT01674192 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopy
NCT02781493 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects
NCT01870674 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Prucalopride in Male Subjects With Chronic Constipation.
NCT01147926 ·Status: COMPLETED ·Phase: PHASE3
-
The Plecanatide Chronic Idiopathic Constipation (CIC) Study
NCT01429987 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Prokinetics With Split Dose of PEG in Morning Colonoscopic Bowel Preparation
NCT01513096 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory Pathway
NCT02425774 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Prucalopride on Gastric Emptying in Intensive Care Unit Patients
NCT05496179 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Long-term Prucalopride Treatment With Chronic Constipation in Subjects Aged ≥ 18 Years
NCT01424228 ·Status: COMPLETED ·Phase: PHASE4
-
Prucalopride Versus Placebo in Gastroparesis
NCT02510976 ·Status: TERMINATED ·Phase: PHASE4